Editorial: The plot thickens: Hemoconcentration, renal function, and survival in heart failure

Circulation

Volumn 122, Issue 3, 2010, Pages 233-235

  Katz, Stuart D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN II; CREATININE; LOOP DIURETIC AGENT; VASCULOTROPIN; DIURETIC AGENT;

ALBUMIN BLOOD LEVEL; ARTERY PERFUSION; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; EDITORIAL; GLOMERULUS FILTRATION; HEART FAILURE; HEMATOCRIT; HEMOCONCENTRATION; HOSPITAL READMISSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY VEIN; MITRAL VALVE REGURGITATION; MORTALITY; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATHOGENESIS; PRIORITY JOURNAL; SKELETAL MUSCLE; SODIUM ABSORPTION; SURVIVAL; ULTRAFILTRATION; VASCULAR RESISTANCE; VASOCONSTRICTION; VENOUS PRESSURE; WATER ABSORPTION; BLOOD VOLUME; HUMAN; KIDNEY; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD VOLUME; DIURETICS; HEART FAILURE; HEMATOCRIT; HUMANS; KIDNEY;

EID: 77954952239     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.965293     Document Type: Editorial

References (20)

1. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13:599-608.
2. Shamseddin MK, Parfrey PS. Mechanisms of the cardiorenal syndromes. Nature reviews. 2009;5:641-649.
3. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005;365:417-430.
4. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE Registry. Cardiology. 2008;113:12-19.
5. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis. Ann Intern Med. 1985;103(1):1-6.
6. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002;105:1348-1353.
7. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Eng J Med. 1995;332:647-655.
8. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circ Heart Fail. 2005;112:e154-e235.
9. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122: 265-272.
10. Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol. 2004;93:1254-1259.
11. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345:574-581.
12. Stevenson LW, Tillisch JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, Kobashigawa J, Walden J. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomy-opathy. Am J Cardiol. 1990;66:1348-1354.
13. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-596.
14. Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007;9:872-878.
15. Keren G, Katz S, Strom J, Sonnenblick EH, LeJemtel TH. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation. 1989;80:306-313.
16. Colombo PC, Rastogi S, Onat D, Zaca V, Gupta RC, Jorde UP, Sabbah HN. Activation of endothelial cells in conduit veins of dogs with heart failure and veins of normal dogs after vascular stretch by acute volume loading. J Card Fail. 2009;15:457-463.
17. Sinoway L, Minotti J, Musch T, Goldner D, Davis D, Leaman D, Zelis R. Enhanced metabolic vasodilation secondary to diuretic therapy in decom-pensated congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1987;60:107-111.
18. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625-1633.
19. Bourge R.C. Abraham W.T. Adamson P.B. Aaron M.F. Aranda Jr. J.M. Magalski A. Zile M.R. Smith A.L. Smart F.W. Ma O. Jessup M.L. Sparks B. Naftel D.L. Stevenson L.W. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study J Am Coll Cardiol 2008 51 1073-1079.
20. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51:1073-1079. 20. Porapakkham P, Zimmet H, Billah B, Krum H. B-type natriuretic peptide-guided heart failure therapy: a meta-analysis. Arch Intern Med. 2010; 170:507-514.